Scarica l'app Stockscreener
2.84
8.40%
0.22
Dopo l'orario di chiusura:
2.87
0.03
+1.06%
Oncology Institute Inc Borsa (TOI) Ultime notizie
B. Riley’s Price Target Boost Signals Growth for Oncology Institute - StocksToTrade
Oncology Institute (TOI) Q4 Loss Per Share Improvement Tests Longstanding Profitability Doubts - simplywall.st
Oncology Institute Updates Investors With New Presentation - TipRanks
The Oncology Institute (NASDAQ: TOI) furnishes updated investor presentation - Stock Titan
Oncology Institute’s Q4 Surprises Stir Investor Interest - StocksToTrade
Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga
The Oncology Institute Inc (TOI) Q4 2025 Earnings Call Highlights: Record Revenue and First ... By GuruFocus - Investing.com Canada
Oncology Institute Q4 Earnings Call Highlights - Yahoo Finance
The Oncology Institute: Value-Based Cancer Care Model, Growth Strategy, and Market Expansion Overview 32 - Minichart
Earnings call transcript: Oncology Institute Q4 2025 beats EPS estimates, stock rises - Investing.com
Oncology Institute 2025 10-K: $502.7M Revenue, $(0.54) EPS - TradingView
The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026 - The Manila Times
The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance ... - Bluefield Daily Telegraph
Cancer clinic network aims for positive adjusted EBITDA in 2026 - Stock Titan
Oncology Institute Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
TOI: BTIG Reiterates Buy Rating, Maintains $7 Price Target | TOI Stock News - GuruFocus
Oncology Institute (NASDAQ:TOI) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
Oncology Institute's (TOI) Buy Rating Reaffirmed at BTIG Research - MarketBeat
Oncology Institute (TOI) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Aug Momentum: Should you avoid The Oncology Institute Inc stock right now2025 Buyback Activity & Real-Time Buy Zone Alerts - baoquankhu1.vn
Risk Report: What is The Oncology Institute Inc Equity Warrants revenue forecastVolume Spike & Expert Verified Movement Alerts - baoquankhu1.vn
Risk Report: What analysts say about The Oncology Institute Inc stockEntry Point & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Street Watch: What are the risks of holding The Oncology Institute Inc Equity WarrantJuly 2025 Selloffs & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute - The Manila Times
Comparing Sera Prognostics (NASDAQ:SERA) & Oncology Institute (NASDAQ:TOI) - Defense World
The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call - The Manila Times
The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March - The Manila Times
Risk Report: What is The Oncology Institute Inc Equity Warrants market position2025 Trade Ideas & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Aug Decliners: Is The Oncology Institute Inc impacted by rising ratesEarnings Growth Report & Safe Entry Point Identification - baoquankhu1.vn
The Oncology Institute appoints Kim Tzoumakas to board By Investing.com - Investing.com India
The Oncology Institute appoints Kim Tzoumakas to board - Investing.com Australia
Oncology Institute Adds Independent Director to Board - TipRanks
Kim Tzoumakas joins The Oncology Institute (NASDAQ: TOI) board - Stock Titan
Buyout Rumor: Is The Oncology Institute Inc impacted by rising ratesQuarterly Trade Summary & AI Driven Stock Reports - baoquankhu1.vn
The Oncology Institute Appoints Kim Tzoumakas to Board of Directors - Bitget
Does The Oncology Institute Inc. Equity Warrant have pricing powerJuly 2025 Gainers & Free Weekly Chart Analysis and Trade Guides - mfd.ru
Is The Oncology Institute Inc. forming a bullish divergenceJuly 2025 PreEarnings & Low Risk High Win Rate Picks - mfd.ru
CEO Change: Why is The Oncology Institute Inc. stock going upJuly 2025 Market Mood & Reliable Breakout Stock Forecasts - mfd.ru
How The Oncology Institute Inc. stock reacts to global recession fears2025 Breakouts & Breakdowns & Stepwise Swing Trade Plans - mfd.ru
MSN Money - MSN
Is The Oncology Institute Inc. Equity Warrant stock supported by strong fundamentals2025 Performance Recap & Low Risk Growth Stock Ideas - mfd.ru
Is The Oncology Institute Inc. Equity Warrant a potential multi baggerPortfolio Gains Summary & Free AI Powered Buy and Sell Recommendations - mfd.ru
History Review: Should you avoid The Oncology Institute Inc Equity Warrant stock right nowLong Setup & Daily Momentum Trading Reports - baoquankhu1.vn
Is The Oncology Institute Inc. Equity Warrant’s ROE strong enoughCPI Data & Fast Entry Momentum Trade Alerts - mfd.ru
Risk Report: Is MGRC attractive at current valuation2025 Retail Activity & AI Driven Stock Reports - baoquankhu1.vn
Valuation Update: Can The Oncology Institute Inc continue delivering strong returns2025 Pullback Review & Weekly Watchlist of Top Performers - baoquankhu1.vn
Dividend Watch: Can The Oncology Institute Inc beat the S P 500Weekly Stock Summary & Fast Entry Momentum Alerts - baoquankhu1.vn
CenterBook Partners LP Increases Stock Holdings in The Oncology Institute, Inc. $TOI - MarketBeat
Bull Run: Does ELPW have high return on assets2025 Key Highlights & Safe Entry Zone Identification - baoquankhu1.vn
Why is The Oncology Institute Inc. stock going upWeekly Investment Report & Scalable Portfolio Growth Methods - mfd.ru
Aug Ideas: Can The Oncology Institute Inc benefit from deglobalizationJuly 2025 Momentum & Breakout Confirmation Trade Signals - baoquankhu1.vn
The Oncology Institute, Inc. $TOI Stake Lowered by Tiff Advisory Services LLC - MarketBeat
What analysts say about The Oncology Institute Inc. stockEarnings Trend Report & Reliable Trade Execution Plans - mfd.ru
Published on: 2026-02-13 20:56:16 - mfd.ru
Insider Buy: Is The Oncology Institute Inc. stock positioned for digital transformationJuly 2025 Spike Watch & Fast Exit and Entry Strategy Plans - mfd.ru
0.34%
3.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):